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Some human immunodeficiency virus type 1 (HIV-1) -in-
Next to the immune response, host genetic factors may influence the length of the asymptomatic period. Several combifected persons maintain high and stable CD4 T cell counts and nations of histocompatibility complex genes [9] are associated normal T cell function and remain free of clinical symptoms for with the length of the asymptomatic period. Also, heterozygosprolonged periods of time [1] . Concomitantly, these persons, ity for a 32-bp deletion in the gene of one of the cofactors classified as long-term survivors of HIV-1 infection (LTS), for HIV-1 entry, the C-C chemokine receptor 5 [10 -13] , was have lower virus load than do persons with progressive disease associated with longer AIDS-free survival [14, 15] . [2 -4] .
Viral characteristics, such as cytotropism, cytopathicity, and The absence of progression in LTS may be determined by replicative capacity, have been associated with different stages an interplay between host factors and viral factors. Both huof infection, suggesting an important role for HIV-1 phenotype moral and cellular immune responses have been implicated in the clinical course of HIV infection [16 -23] . On sexual, in long-term survival. In LTS, high titers of antibodies with vertical, and parenteral transmission, infection seems to be initineutralizing activity have been detected [2, 3] , although other ated by macrophage-tropic variants [18, 24] , while a shift from studies reported no differences in neutralizing capacity between preferentially macrophage-tropic to preferentially T cell -tropic antibodies derived from LTS and progressors [4, 5] . Strong HIV-1 populations is correlated with progression to disease and persistent cytotoxic T lymphocyte (CTL) responses against [19] . In 50% of persons, this shift is associated with the emerseveral HIV-1 epitopes have been detected in LTS; however, gence of syncytium-inducing (SI) variants [25] . Persons develvigorous CTL responses are also readily detected during the oping SI variants show an increased virus load, accelerated asymptomatic phase in progressors [6 -8] .
CD4 T cell loss, and rapid progression to AIDS compared with persons harboring solely non -syncytium-inducing (NSI) variants [21, 25 -27] . LTS and progressors in this study were analyzed.
Analysis of CD4 T cell counts. T lymphocyte immunophenotyping for the CD4 T cells was carried out at 3-month intervals by flow cytofluorometry. PBMC were stained with CD4 monoclonal antibody according to standard procedures for cell cytometric analysis.
Materials and Methods
Virus isolation and determination of infectious cellular virus load. Virus was isolated under limiting diluting conditions as Subjects. By October 1994, 12 participants of the Amsterdam previously described [19, 27] . Briefly, participant PBMC (0.5-Cohort studies on AIDS had an asymptomatic follow-up of at least 4 1 10 4 cells/well in 48 or 96 wells) were cocultivated with 9 years with a relatively normal mean CD4 T cell count (ú400/ phytohemagglutinin (PHA)-stimulated healthy donor PBMC (10 5 / mm 3 ). Additionally, these persons harbored solely NSI variants well) in 96-well microtiter plates. Every week, culture supernatants and did not receive any anti-HIV drug treatment during the course were tested for p24 antigen by an in-house p24 antigen-capture of infection. These persons were termed LTS [1] . Seven of these ELISA [32] . PBMC, MT2 cells (1 1 10 6 ) were added to analyze syncytium-buffer containing guanidinethiocyanate, Triton X-100, and Tris-HCl. Three synthetic RNAs (QA, QB, QC) of known high, me-inducing capacity of the virus clones [33] .
Quantification of RNA in serum. HIV-1 RNA was quantified dium, and low concentration, respectively, were added to the lysis buffer containing the released nucleic acid. These Q-RNAs served in serum by using a nucleic acid sequence-based amplification assay (HIV-1 RNA QT; Organon Teknika, Boxtel, Netherlands).
as internal calibrators, each differing from the HIV-1 wild type RNA by only a small sequence [34] . One hundred microliters of serum was added to 900 mL of lysis From each virus clone, 1250 TCID 50 was added to 5 1 10 6 PHA-stimulated PBMC derived from the same donor on which the TCID 50 was determined. To keep the volume of the inocula from exceeding 1.25 mL, virus stocks with õ10 3 TCID 50 /mL were excluded from replication analysis. Virus and PBMC were incubated in a 1.5-mL volume for 2 h at 37ЊC. PBMC were then washed, resuspended in 5 mL of fresh recombinant interleukin-2 (20 U/mL; PROLEUKIN; Chiron, Amsterdam)-supplemented medium, and cultured for 16 days.
To determine the kinetics of virus production, 75 mL of the culture supernatant was harvested every second day and stored at 4ЊC until analysis. At day 8 of culture, 4 1 10 6 freshly PHAstimulated PBMC in 2 mL of medium were added to the cultures. Supernatants harvested at all different time points were analyzed for the presence of virus in an in-house p24 antigen-capture ELISA [32] . p24 production per milliliter of supernatant was deter- Figure 1 . Replication kinetics of biologic virus clones. Healthy domined and corrected for the differences in volume of culture supernor peripheral blood mononuclear cells that had been stimulated with natants between the moments of sampling. phytohemagglutinin were infected with 1250 TCID 50 of biologic virus nef sequence analysis. From 10 6 infected PBMC, obtained clones obtained from LTS (A) and disease progressors (B) early (I) after propagation of the clonal virus stocks, proviral DNA was and late (II) in infection. Cultures were maintained for 16 days, and isolated. PBMC were lysed in L6 lysis buffer (0.08 M GuSCN new target cells were added on day 8. p24 production in supernatant [Life Technologies Gibco BRL, Gaithersburg, MD], 0.08 M Trisharvested every second day was measured. Replication phenotype Cl, pH 6.4, 0.035 M EDTA, 2% (wt/vol) Triton X-100) [35] and (C) was based on mean values for increase in p24 production during stored at 070ЊC until use. DNA was precipitated by addition of days 4 and 8 of culture and maximal p24 production reached within 14 days of culture. Open symbols, slow-replicating; solid symbols, isopropanol in a 1:1 ratio (vol/vol) and centrifugation for 15 min rapid-replicating; shaded symbols, intermediate. at 13,000 g. DNA pellets were washed twice with 70% ethanol and resuspended in water. nef DNA was amplified by a nested polymerase chain reaction Subsequently, RNA was isolated as previously described [4] .
(PCR) with primers Nef A (nt 2408-2428 in relation to the SF2 Amplification of wild type HIV-1 RNA and Q-RNAs is based on env sequence: 5-GTCTAGAACTAAAGAATAGTG-3, sense primer extension of primer 1 (nt 682-711 in relation to the HX2B orientation) and LTR BCAT (nt 519-545 of the LTR sequence: 5gag sequence, 5-ACTCTCTTGGTTCCCCTTCACTGTATCGT-GCACTCAAGGCAAGCTTTATTGAGGC-3, antisense) in the GCCATATCACTCAGCATAATCTTAA-3; antisense; T7-RNA first reaction and primers Nef B (nt 2526-2546 of the env sepolymerase recognition site underlined), by avian myeloblastosis quence: 5-ATCTAGAAGAATAAGACAGGG-3, sense) and Nef virus reverse transcriptase (AMV-RT). Extension is followed by C (nt 350-370 of the LTR sequence: 5-AAGTCTAGAGCGdegradation of the template RNAs by RNase H, synthesis of the GAAAGTCCC-3, antisense) for the second reaction. second DNA strand through extension of primer 2 (nt 569-590: 5-For both reactions, DNA was denatured for 5 min at 95ЊC, AGTGGGGGGGACATCAAGCAGCCATGCAAA-3) by AMVfollowed by 30 cycles of 1.5 min of denaturation at 95ЊC, 1.5 min RT, and cyclic and isothermal (41ЊC for 90 min) RNA synthesis of annealing at 48ЊC, and 1.5 min of extension at 72ЊC, and a by T7-RNA polymerase. subsequent extra 5-min extension at 72ЊC and soaking at 4ЊC. Five Amplificates were hybridized with an HIV-1-specific beadmicroliters of DNA was amplified in 50-mL reactions containing oligo (i.e., a biotin-oligo bound to streptavidin-coated magnetic 11 Taq buffer (Promega, Madison, WI), 0.2 mM each dNTP, 100 beads acting as solid phase) and ruthenium-labeled probes, each ng of each primer, 1.5 mM MgCl 2 , and 1 U of Taq DNA polymerspecific for the wild type and control amplificates. Magnetic beads ase (Promega). Five microliters of the first reaction was used as carrying the hybridized amplificate-probe complex are captured input for the nested PCR reaction. PCR products were purified by on the surface of an electrode by means of a magnet. Voltage use of a spin PCR purification kit (Qiagen, Chatsworth, CA). applied to this electrode triggers the electrochemoluminescence
The positive strands were sequenced by use of Sequenase DNA reaction, and the light emitted by the hybridized ruthenium-labeled polymerase (United States Biochemicals, Cleveland) with primers probes is proportional to the amount of amplificate.
Nef (table 1) , were analyzed with respect to their replicative capacity ( figure 1A, B ). The replicative capacity of each virus was reflected by the rate of p24 accumulation early in culture (between days 4 and 8) and the maximum levels of p24 production reached within 14 days of culture.
The mean increase in p24 production between days 4 and 8 of culture (0.25 mg/mL) and the mean maximal p24 production (1.26 mg/mL) of all viruses analyzed were used as reference for determining the replication phenotype of each single virus clone ( figure 1C ). Variants with a p24 increase between days 4 and 8 and a maximal p24 production above average were typed rapid (upper right quadrant in figure 1C ; mean values, 0.5 mg/mL and 1.6 mg/mL, respectively); variants with both measures below average were typed slow (lower left quadrant in figure 1C ; mean values, 0.1 mg/mL and 0.9 mg/mL). Viruses with only one measure above average were typed as variants with intermediate replicative capacity (upper left and lower right quadrants; mean values, 0.2 mg/mL and 1.2 mg/mL). The mean values of both measures were significantly different between the 3 phenotypically distinct groups (P õ .001).
At the early time point, all participants carried viruses with relatively low replication kinetics. Only LTS L6 and L7 additionally had viruses with high replication kinetics at this time point. In 4 of the 8 LTS (L1 -L4), all late-stage viruses that were analyzed also had relatively low replication kinetics; L4 even seemed to have developed less-replication-competent viruses over time.
Three LTS (L5 -L7) and the progressors (P1 -P3) had viruses with high replicative capacity late in infection. In these subjects (with the exception of L7), the proportion of rapidreplicating viruses had increased compared with that at the 1) . For each subject, the infectious cellular load at this time ure 2A).
Because of the low virus load, õ5 biologic clones were point, consisting solely of NSI variants, is given in table 2. For comparison of replicative capacity, slow-(n Å 7) and rapid-obtained at the early time point for most persons (table 1) . From 3 of these (L4, L5, and P3), the replication kinetics of replicating viruses (n Å 7) from the first experiment were included. virus clones from an additional time point were analyzed, Ç1 year after the early time point. Also at this time point, only
In contrast to the rapid-replicating control viruses, which first showed detectable p24 production at days 2-6 of culture, the viruses with relatively low replicative capacity were present (data not shown), and the cellular virus load was still low (see slow-replicating control viruses did not produce detectable p24 levels until days 10-14 of culture. Therefore, the viruses from also figure 3) .
The 4 LTS (L1 -L4) who only had slow-and intermediate-P4-P8 were not classified by the combination of their increase in p24 production between days 4 and 8 of culture and the maxi-replicating viruses late in infection also maintained a low infectious cellular load (1 -29 TCID/10 6 CD4 T cells). Interestingly, mum p24 production, as in the first experiment, but by the combination of the first day of detection and maximal p24 production all 3 progressors and the 3 LTS (L5 -L7) with rapid-replicating variants late in infection had a high cellular load at this time relative to the means of the control viruses (day 8 and 0.2 mg/ mL respectively). In progressors P5-P8, but not in P4, who had point (83 -288 TCID/10 6 CD4 T cells) ( figure 2B) .
We additionally analyzed the replicative capacity of biologic a low infectious cellular load at the time point of analysis, viruses with high replicative capacity were detected (table 2) . virus clones derived from 5 persons with a progressive disease nef sequence analysis. It has previously been demonstrated that some LTS harbor HIV-1 variants with a defective nef gene P õ .001).
Infectious cellular load and RNA load in serum. It could be [28 -31] . We analyzed whether the slow replication kinetics of viruses studied here also resulted from the presence of defective argued that a high infectious cellular load, in particular the high load observed in 3 of the LTS, might be an in vitro artifact nef genes. nef sequences of the slow-replicating biologic virus clones of L1 -L4 were analyzed. In addition, nef sequences of caused by activation of latently infected cells during culture procedures. Therefore, we analyzed the RNA levels in serum both slow-and rapid-replicating virus clones of L6 and of progressors P1 -P3 were analyzed ( figure 4) . samples obtained at the late time points for all study participants (with the exception of P6). In agreement with our previous Intersubject variation in nef sequences was observed, yet previously described functional domains [37] were generally observations [36] , the log-transformed values of both measures of virus load were significantly correlated (Spearman correlation intact. No specific mutations could be related to the viruses from either progressors or LTS nor to slow-or rapid-replicating coefficient Å .76, P Å .002). The low infectious cellular load in L1-L4 was accompanied by a low RNA serum load (õ10 4 viruses. In 4 subjects, the majority of viruses had an insertion of 4 aa at position 25. However, this insertion was observed RNA copies/mL of serum), while L5-L7 and the progressors had both a high infectious cellular and a high serum RNA load in viruses with different phenotypes. Mutations in the (PxxP) 3 domain (proline repeat sequence; position 69 -78) were ob-(ú10 4 RNA copies/mL of serum) (see also figure 3 ).
Virus load in relation to clinical course. The finding of served in all viruses of L1 and in all late viruses of L2. The R-to-K substitution at position 71 in this domain has been LTS with high virus load raised the question of whether this high load reflected the onset of disease progression in these described previously for variants from LTS [37] , although the nef sequences of these particular variants were shown to be subjects. However, during the 1-to 2-year follow-up period beyond the late time point, the CD4 T cell counts in L5 -L7 functional in vitro [38] . All viruses of L3 had a cysteine at position 138, recently described to affect replication capacity remained relatively stable ( figure 3) . Analysis of the infectious cellular virus load and viral RNA in serum at several additional in H9 cells [30] . However, this same mutation was also present in the nef of the rapid-replicating viruses isolated from the time points during follow-up of these LTS revealed a relatively high cellular load (78 and 74 TCID/10 6 CD4 T cells, respec-typical progressor P2 at the moment of AIDS diagnosis. Possible dysfunctional nef genes were observed in the viruses tively), even at earlier time points in L6 and L7.
The time span between detection of a high load and the most with slow kinetics of L4, which had a 4-aa deletion at positions 156 -159. This deletion was present in at least one of the viruses recent measurement of high CD4 T cell counts was 43, 70, and 59 months for L5, L6, and L7, respectively. During this isolated from PBMC in 1989 and was still present in all 3 viruses isolated from PBMC in 1992. period, the number of CD4 T cells remained relatively stable (decline 41, 13, and 1 CD4 T cell/mL/year for L5, L6, and L7 respectively). In contrast, the CD4 T cell decline observed in Discussion the progressors (P1 -P3 and P8) appeared to coincide with or even precede the moment of first detection of high infectious A small number of HIV-infected persons harboring solely NSI variants show no signs of progression to disease. However, cellular load (CD4 T cell decline between moment of first detection of high infectious cellular load and AIDS diagnosis:
50% of all AIDS patients also harbor solely NSI variants. The absence of SI variants therefore cannot be the sole explanation 117, 82, 97, and 66 CD4 T cells/mL/year for P1, P2, L3, and P8, respectively).
for absence of disease progression. Next to a role for host / 9d41$$mr07 01-12-98 08:47:21 jinfa UC: J Infect / 9d41$$mr07 01-12-98 08:47:21 jinfa UC: J Infect factors [2, 6 -8, 14, 15] , viral characteristics other than syncy-sioned that increased viral replicative capacity, which causes the increase in virus load, is not necessarily associated with tium-inducing capacity might contribute to the differential clinical course observed between HIV-1 -infected persons. Here increased cytopathicity of these viruses. Indeed, viruses isolated from persons with differing progression rates yet similar we tested the hypothesis that NSI variants present in LTS may have relatively attenuated replication capacity and are unable virus load were found to be differentially cytopathic in a SCIDhu mouse model [51] . to achieve a high virus load in vivo, thereby explaining at least in part the beneficial clinical course observed in LTS. After 6.6 (L4) or even ú9 years of infection, 4 LTS still harbored slow-replicating variants. To explain the absence of Biologic virus clones were isolated from 7 LTS and 8 subjects with progressive HIV-1 infection and analyzed for their evolution to variants with a more rapid phenotype, several hypotheses might be envisioned. First, viruses are under selec-replicative potential. Early in infection, all participants analyzed had relatively slow-replicating viruses. Two LTS who tive pressure by host cellular immune responses. The persisting slow-replicating viruses in our study subjects may be best had the highest infectious cellular load at the early point of analysis additionally had rapid-replicating variants at this time adapted to withstand cellular immunity, whereas changes associated with more rapid replicative capacity may generate epi-point.
At the time point late in infection, still only relatively slow-topes that are well-recognized by CTL, causing immediate elimination of that variant. It has been postulated previously replicating viruses could be detected in 4 LTS. Accordingly, these LTS maintained low levels of RNA in serum as well as that the presence of CTL directed against conserved epitopes prevents the evolution of virus populations [52] . In this view, a low infectious cellular load. This is in agreement with the recently described low levels of viral mRNA transcripts late the slow-replicating variants may have mutations in relatively conserved sequences that allow them to escape immune surveil-in infection in LTS [39] . In contrast, from the other 3 LTS and the progressors late in infection, either solely rapid-replicating lance yet at the same time result in severe attenuation. Next to specific immune pressure, viral characteristics may viruses or coexisting rapid-and relatively slow-replicating viruses were detected. These persons all had an increased virus play a role in virus evolution. It is conceivable that the virus variants that establish infection in a particular person, compared load, suggestive of a correlation between in vitro HIV-1 replicative capacity and virus load in vivo.
with the initial variants in another person, are genetically closer to a genotype that is associated with more rapid replication. In Increasing cellular load as well as RNA load has been associated with CD4 T cell decline and disease progression [2, 3, this case, it would be just a matter of time to allow accumulation of relevant mutations [53] . Finally, low replication kinetics might 21, 27, 40 -43] . It is therefore conceivable that the high load in 3 of the LTS is a sign of progression. However, these 3 be due to aberrations in HIV-1 regulatory genes [54, 55] . The best-studied in this respect is the nef gene. The absence LTS maintained high and relatively stable CD4 T cell counts for a subsequent 43 -70 months, suggesting that some LTS of functional nef was associated with a lack of viral pathogenicity in the SCID-hu mouse model [56] and in simian immunode-remain healthy for prolonged periods of time despite the presence of rapid-replicating viruses and a high virus load. In sup-ficiency virus strain mac -infected rhesus monkeys [57] . This is in agreement with the observation that nef is required for port of this, Rump et al. [44] recently reported the existence of LTS with continuously high virus load as measured by serum efficient replication in primary cells [58 -60] . More recently, nef was associated with HIV-1 pathogenesis in humans by the p24 antigen.
The maintenance of relatively stable CD4 T cell numbers in finding that some LTS have HIV-1 variants with defective nef genes [28 -31] . the face of increasing infectious load can have several explanations. In agreement with the low frequencies of infected cells Some of the slow-replicating viruses in our study carried changes in nef. Some of these changes have been observed in lymph nodes [45] , the magnitude of CD4 T cell turnover seems to be much smaller [46] than previously suggested [47, before in LTS [37] but were not associated with attenuated function in vitro [38] . It has been suggested that a cysteine 48]. The loss of CD4 T cells might then be explained from a combination of HIV-1 -mediated killing and a failing homeo-residue at position 138 may attenuate nef function [30] . However, the presence of a cysteine at this position in nef of slow-stasis. The capacity by which new T cells can be generated might be genetically determined, thereby contributing to differ-as well as rapid-replicating viruses in our study supports the finding that this mutation is irrelevant for nef function [38] . ences in CD4 T cell decline between individuals. Additionally, the low degree of CD4 T cell depletion might With the exception of L4, who had viruses with a relatively large deletion in the nef gene, it seems unlikely that deviations be due to the absence of an effective anti-HIV CTL response [49] . In support of this, only low frequencies of CTL precursors in nef contribute to the absence of disease progression in the group of LTS studied here. directed against epitopes of multiple HIV-1 proteins have been observed in participant L6 (Pontesilli O, personal communica-In conclusion, we have shown that some persons classified as LTS persistently harbored slow-replicating viruses associ-tion).
Finally, since viral cytopathicity may be a mechanism ated with a low virus load, which might explain the absence of progression in these persons. The existence of LTS with through which CD4 T cells are depleted [50] , it could be envi-/ 9d41$$mr07 01-12-98 08:47:21 jinfa UC: J Infect 
